Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 976 AL 990

Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease

Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM.

JAMA Neurol. 2015 Jun;72(6):656-65. doi: 10.1001/jamaneurol.2015.0202.

Preanalytical variables and Alzheimer disease biomarker concentrations in cerebrospinal fluid

Florkowski CM.

Clin Chem. 2015 May;61(5):686-8. doi: 10.1373/clinchem.2015.240069. Epub 2015 Apr 13.

Directed network motifs in Alzheimer's disease and mild cognitive impairment

Friedman EJ, Young K, Tremper G, Liang J, Landsberg AS, Schuff N; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2015 Apr 16;10(4):e0124453. doi: 10.1371/journal.pone.0124453. eCollection 2015.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study

Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.

BMC Neurol. 2015 Apr 1;15:51. doi: 10.1186/s12883-015-0298-0.

Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update

Bradley-Whitman MA, Lovell MA.

Arch Toxicol. 2015 Jul;89(7):1035-44. doi: 10.1007/s00204-015-1517-6. Epub 2015 Apr 18.

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease

Sweeney MD, Sagare AP, Zlokovic BV.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1055-68. doi: 10.1038/jcbfm.2015.76. Epub 2015 Apr 22.

Equivalence of kernel machine regression and kernel distance covariance for multidimensional phenotype association studies

Hua WY, Ghosh D.

Biometrics. 2015 Sep;71(3):812-20. doi: 10.1111/biom.12314. Epub 2015 May 1.

Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease

Plagg B, Marksteiner J, Kniewallner KM, Humpel C.

Biogerontology. 2015 Aug;16(4):543-58. doi: 10.1007/s10522-015-9580-1. Epub 2015 May 7.

Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)

Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network.

Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

Rostgaard N, Waldemar G, Nielsen JE, Simonsen AH.

Dement Geriatr Cogn Disord. 2015;40(1-2):54-62. doi: 10.1159/000381828. Epub 2015 May 13.

[Biomarkers for early diagnosis of Alzheimer's disease]

Frederiksen KS, Hasselbalch S, Law I, Højgaard L, Waldemar G.

Ugeskr Laeger. 2015 Jun 8;177(24):V12140684.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.

Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease

Li Y, Wang J, Zhang S, Liu Z.

J Neurosci Res. 2015 Sep;93(9):1325-9. doi: 10.1002/jnr.23564. Epub 2015 Jun 11.

Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?

Dubroff JG, Nasrallah IM.

Acad Radiol. 2015 Aug;22(8):988-94. doi: 10.1016/j.acra.2015.02.005. Epub 2015 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias